Why is Biofil Chemicals falling/rising?

As of 21-Jul, Biofil Chemicals & Pharmaceuticals Ltd's stock price is currently at Rs 46.80, reflecting an increase of Rs 1.0 or 2.18%. The stock has shown a positive performance today, outperforming its sector by 2.5% and reaching an intraday high of Rs 46.95. In the short term, the stock has demonstrated a slight gain of 0.11% over the past week and 0.65% over the past month. However, it has faced significant challenges, with a year-to-date decline of 17.89% and a one-year drop of 23.03%. The company's weak long-term fundamentals, including a -20.95% CAGR growth in operating profits over the last five years and a poor EBIT to Interest ratio of 0.74, contribute to its overall underperformance. Additionally, the stock's return on equity is low at 4.50%, indicating limited profitability per unit of shareholder funds, which may deter long-term investors.
In the broader market context, while Biofil Chemicals has outperformed the Sensex by 2.5% today, it has consistently underperformed against the benchmark over the last three years, with a return of -23.03% compared to the Sensex's positive 1.98% over the same period. The stock's liquidity appears adequate, with a significant increase in delivery volume, suggesting rising investor participation. However, the company's flat results and declining net sales, which have decreased by 33.62%, highlight ongoing operational challenges that could hinder future performance. Overall, despite today's rise, the stock's long-term outlook remains concerning due to its fundamental weaknesses and historical underperformance against market benchmarks.